C-U 0002042609 XXXXXXXX 020-37169 LIVE false false false The Offering successfully reached its Target Offering Amount on July 6, 2026, having closed on funds totaling $42,352.43. Eliaz Therapeutics Inc. Corporation DE 09-17-2015 398 TESCONI COURT SANTA ROSA CA 95401 https://www.eliaztherapeutics.com Y Eliaz Therapeutics CF Investors SPV, LLC Limited Liability Company DE 03-18-2026 398 Tesconi Court Santa Rosa CA 95401 DEALMAKER SECURITIES LLC 0001872856 008-70756 000315324 The Issuer will pay DealMaker Securities LLC an 8.5% cash commission fee based on the dollar amount of the Securities sold in the Offering. There is also a one-time $38,000 fee and a $15,000 monthly fee payable to DealMaker Securities LLC or its affiliates None. Other Class B Common Stock 1747 5.56000 10004.72 Y Other At the Company's discretion 2999995.63 04-15-2027 2.00 2589276.00 738015.00 1799510.00 32814.00 0.00 0.00 1796731.00 2346085.00 8033117.00 3888186.00 332235.00 302481.00 0.00 0.00 0.00 0.00 -1745041.00 -954869.00 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY Eliaz Therapeutics Inc. Dr. Isaac Eliaz CEO Dr. Isaac Eliaz Director 07-07-2026